Duration of Study:
24 months.
Number of participants:
70
Participating centres:
- University Hospital of North Midlands, Stoke on Trent, United Kingdom
- Birmingham Women’s and Children NHS Foundation Trust, Birmingham, United Kingdom.
Funded by:
National Institute for Health Research, (Research for Patient benefit)
Chief Investigator:
- Mr. Gourab Misra, FRCOG, Diploma in Advanced Gynecological Endoscopy, MCH Robotic Surgery, (Consultant Gynecologist University Hospital of North Midlands)
- Professor Thomas Justin Clark, FRCOG, MD (Hons), DFFP, Consultant Gynecologist at Birmingham Women’s and Children NHS Foundation Trust.
If you are eligible, would like to take part and your local hospital is a study site, they will send you information about the ICE study.
To take part you will be asked to sign a consent form and asked some questions about your health and your endometriosis symptoms. After this you will be randomised to receive:
Group 1 (traditional technique stents):
A small stent (soft tube) will be temporarily placed in each ureter to identify and protect it during surgery. The stents are either removed at the end of the operation or may be left in for4-6 weeks.
Group 2 (new technique dye):
The dye will be injected through a ureteric catheter into each ureter. This dye allows surgeons to see the ureters under a special light.
Whichever group you are in, you will continue to receive NHS care. We will follow you up in the study for 12 weeks using by sending questionnaires for you to complete at home.
There is an extra part of the study that is optional. In this extra part, we will ask some participants to take part in a focus group.
If you agree to take part in the ICE study, we will ask you whether or not you would like to receive information about these focus groups and to be contacted by the facilitators.